---
title: Cardiologent: Multi-Agent Clinical Decision Support for Patient-Level Arrhythmia Assessment, Urgency, and Management
url: http://arxiv.org/abs/2607.25340v1
type: paper-summary
date: 2026-07-28
source_paper: 2026-07-28_06-43-39Z_Cardiologent_Multi_AgentClinicalDecisionSupportfor.md
generated_at: 2026-07-28 22:03
model: nvidia/nemotron-3-nano-4b
---

## Summary
This paper introduces Cardiologent, a multi‑agent clinical decision support system that evaluates patient‑level atrial fibrillation beyond simple rhythm naming to determine urgency and management. The agents combine single‑lead ECG and photoplethysmogram features into a rhythm profile, reason against relevant guidelines, and let a critic validate each conclusion against expert cardiologists, yielding auditable decisions.

## Key Takeaways
- Cardiologent treats the entire arrhythmia episode as a unified decision task rather than isolated signal labeling.  
- Each agent grounds its reading in measured features from ECG leads and PPG data, avoiding reliance on raw labels.  
- The system’s conclusions are traceable to cited clinical guidelines and validated against cardiologists, achieving high agreement scores.

## Context
Current AI tools often process single recordings or perform isolated diagnostic tasks, leaving the patient‑level judgment gap unaddressed. This work bridges that gap by integrating multimodal signals into a holistic decision pipeline, reflecting broader efforts toward continuous, context‑aware medical AI.

## Implications
Clinicians can now audit AI recommendations with transparent guideline references, fostering trust in automated monitoring. The approach may enable scalable deployment of patient‑level arrhythmia assessment across large health systems.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2607.25340v1)
